Research at NCVI

The scientific strategy of the Novo Nordisk Foundation Center for Vaccines and Immunity (NCVI)  is centered on gaining a deeper understanding of protective immune responses, both in the body as a whole and specifically within the respiratory tract. NCVI has four key research areas:

  • Airway Immunity
  • Respiratory Pathogens
  • Vaccine Platforms
  • Airway Delivery
Scientific fields

These areas collectively guide NIVI's efforts to develop new and improved vaccines that induce robust protection against our priority pathogens, including:

  • Tuberculosis
  • Influenza
  • Group A Streptococcus

To accomplish this, NCVI is establishing a highly collaborative research environment where interdisciplinary teams work together on crosscutting projects to address key questions within these focus areas.

Scientific fields

Airway Immunity, Respiratory Pathogens, Vaccine Platforms and Airway Delivery.

Multiple labeled vials containing vaccine samples or research materials, partially submerged in crushed ice, to ensure cool storage in a laboratory setting